症状对老年透析前患者健康相关生活质量的影响:EQUAL研究中的效应与重要性
EQUAL研究纳入≥65岁晚期CKD(4/5期)患者,用透析症状指数和RAND-36评估症状数与生活质量的关系。基线1079例中,每增加一个症状,MCS降低0.81、PCS降低0.50;症状数解释22%的MCS变异和11%的PCS变异,而eGFR仅解释1%。结论认为症状对老年透析前患者生活质量影响显著,应在临床决策中更受重视。
要点
- 每增加一个症状,MCS降低0.81、PCS降低0.50。
- 症状数解释22%的MCS变异和11%的PCS变异。
- eGFR仅解释1%的生活质量变异。
核心结论
- 在老年CKD 4/5期透析前患者中,症状对生活质量有实质性影响,症状应在临床决策中占据更突出位置。
研究设计与样本
- EQUAL研究为正在进行的欧洲前瞻性随访研究,纳入2012年3月至2015年12月期间年龄≥65岁的晚期CKD(4/5期)患者。
- 基线问卷由1079例(73%)患者完成,中位年龄75岁,66%为男性,98%为白人;随访6个月问卷由627例(42%)患者完成。
- 症状采用透析症状指数评估,生活质量采用RAND-36健康调查评估,得出躯体成分总结(PCS)和心理成分总结(MCS)。
- 采用线性回归估计基线和6个月时症状与生活质量的关系,并计算症状解释的生活质量变异。
主要发现
- 基线时,每增加一个症状,MCS变化-0.81(95%CI:-0.91至-0.71),PCS变化-0.50(95%CI:-0.62至-0.39)。
- 单变量分析中,症状数解释22%的MCS变异和11%的PCS变异,而估算肾小球滤过率(eGFR)仅解释1%的变异。
临床怎么用
- 在老年晚期CKD透析前患者的临床决策中,应更重视症状评估和管理,而非仅关注肾功能指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Quality of life (QoL) is an important outcome in chronic kidney disease (CKD). Patients feel that symptoms are an important determinant of QoL. However, this relation is unknown. The aims of this study were to investigate the impact of the number and severity of symptoms on QoL in elderly pre-dialysis patients, assessed by both the effect of symptoms and their importance relative to kidney function, and other clinical variables on QoL. METHODS: The European Quality study (EQUAL study) is an ongoing European prospective follow-up study in late Stage 4/5 CKD patients aged ≥65 years. We used patients included between March 2012 and December 2015. Patients scored their symptoms with the Dialysis Symptom Index, and QoL with the research and development-36 (RAND-36) item Health Survey (RAND-36). The RAND-36 results in a physical component summary (PCS) and a mental component summary (MCS). We used linear regression to estimate the relation between symptoms and QoL at baseline and after 6 months, and to calculate the variance in QoL explained by symptoms. RESULTS: The baseline questionnaire was filled in by 1079 (73%) patients (median age 75 years, 66% male, 98% Caucasian), and the follow up questionnaire by 627 (42%) patients. At baseline, every additional symptom changed MCS with -0.81 [95% confidence interval (CI): -0.91 to -0.71] and PCS with -0.50 (95% CI: -0.62 to -0.39). In univariable analyses, number of symptoms explained 22% of MCS variance and 11% of PCS variance, whereas estimated glomerular filtration rate only explained 1%. CONCLUSIONS: In elderly CKD Stage 4/5 patients, symptoms have a substantial impact on QoL. This indicates symptoms should have a more prominent role in clinical decision-making.
引用
- Voskamp PWM, van Diepen M, Evans M, et al. The impact of symptoms on health-related quality of life in elderly pre-dialysis patients: effect and importance in the EQUAL study. Nephrol Dial Transplant. 2019. PMID: 29939304. doi:10.1093/ndt/gfy167
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。